Elder Pharmaceuticals

Last updated

Elder Pharmaceuticals
Company type Public
  • BSE: 532322
  • NSE: ELDERPHARM
Industry Pharmaceuticals, Drugs & healthcare
Founded1989;36 years ago (1989) [1]
FounderJagdish Saxena
Headquarters,
India
ProductsMedicines and Vaccines
RevenueIncrease2.svg 16,743 million (2013) [3]
Increase2.svg 823 million (2013) [3]
Increase2.svg 937 million (2013) [3]
Total assets Increase2.svg 24,924 million (2013) [3]
Total equity Increase2.svg 7,691 million (2013) [3]
Number of employees
4300 [4]
Subsidiaries NeutraHealth, [5] Elvista [6]
Website https://elderpharma.com/

Elder Pharmaceuticals Ltd is a pharmaceutical company headquartered in Mumbai, Maharashtra. [7] Its main activities include the manufacturing and marketing of prescription pharmaceutical brands, surgical and medical devices. Its largest presence in three therapeutic segments, Women's Healthcare, Wound Care and Nutraceuticals. It has 6 manufacturing plants in India & 1 in Nepal. It manufacture various dosage forms like tablets, capsules, syrups, injectables, topical creams and ointments. [8]

Contents

History

In 1989, Jagdish Saxena formed Elder Pharmaceuticals in Mumbai when he lost his job due to the shut down of the pharma division of a company for which he was working. The first manufacturing plant was set up in 1989 at Nerul. It was listed on Bombay Stock Exchange and National Stock Exchange in 2000. [9]

In 2010, the company acquired the UK-based supplements company NeutraHealth for £12.2 million. [10]

On 13 December 2013, Torrent Pharmaceuticals signed a definitive deal to acquire Elder Pharmaceuticals' branded domestic formulations business in India and Nepal for 2,000 crore. [11] Even after the sale, Elder Pharmaceuticals faced a debt crisis. [12] In 2016, the company was delisted from the stock exchanges on account of non-compliances. [13]

In October 2013, founder Jagdish Saxena died. [14] In October 2017, the MD Alok Saxena died at the age of 52. [15] The promoter group was later led by Jagdish Saxena's second son Anuj Saxena, a former TV actor, and daughter Shalini Saxena Kumar, an entrepreneur. [16]

Related Research Articles

<span class="mw-page-title-main">Cipla</span> Indian multinational pharmaceutical company

Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India.

<span class="mw-page-title-main">Dilip Shanghvi</span> Indian Businessman

Dilip Shanghvi is an Indian billionaire businessman. As the founder of Sun Pharmaceuticals, he is one of the country's richest people. The Government of India awarded him the civilian honor of the Padma Shri in 2016. India Today magazine ranked him 8th in India's most powerful people of 2017 list.

<span class="mw-page-title-main">Dr. Reddy's Laboratories</span> Indian multinational pharmaceutical company

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.

<span class="mw-page-title-main">Perrigo</span> Irish tax-registered pharmaceutical

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.

The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.

Torrent Pharmaceuticals Ltd is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.

<span class="mw-page-title-main">Sun Pharma</span> Indian multinational pharmaceutical company

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental and nutritionals. 

<span class="mw-page-title-main">Granules India</span> Indian pharmaceutical company

Granules India Limited is an Indian multinational pharmaceutical manufacturing company based in Hyderabad. Granules manufactures several off-patent drugs, including Paracetamol, Ibuprofen, Metformin and Guaifenesin, on a large scale for customers in the regulated and rest of the world markets. Granules India Limited also operates in the contract research and manufacturing (CRAM) segment.

<span class="mw-page-title-main">Lupin Limited</span> Indian multinational pharmaceutical company

Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.

Unichem Laboratories is an Indian pharmaceutical company, headquartered in Mumbai. It manufactures and markets pharmaceutical formulations across the globe, including the regulated markets of the USA and Europe.

Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals.

<span class="mw-page-title-main">Aurobindo Pharma</span> Indian multinational pharmaceutical company

Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer.

Dishman Carbogen Amcis Ltd is an Indian multinational pharmaceutical company specialized in the manufacture of active ingredients and contract development and manufacturing. Dishman employs over 1,000 people worldwide and is listed on the Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE).

Curia is a contract research and manufacturing organization that provides drug discovery, development, cGMP manufacturing and aseptic fill and finish to the pharmaceutical and biotechnology industries. Founded in 1991, Curia operates in the United States, Europe and Asia, with its headquarters located in Albany, New York. Curia has announced deals and collaborations with such companies as Pfizer Inc., Merck & Co., Eli Lilly and Company, Takeda, Genentech, Bristol-Myers Squibb Co. and GE.

<span class="mw-page-title-main">Piramal Group</span> Indian conglomerate

The Piramal Group is an Indian multinational conglomerate that has presence across various sectors such as healthcare, life sciences, drug discovery, financial services, alternative investment and real estate.

<span class="mw-page-title-main">Alkem Laboratories</span> Indian pharmaceutical company

Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical generics, formulations and nutraceuticals in India and globally.

Alembic Pharmaceuticals Ltd. is an Indian multinational pharmaceutical company headquartered in Vadodara. It is involved in the manufacture of pharmaceutical products, pharmaceutical substances and intermediates. It is also termed to be a market leader in macrolides segment of anti-infective drugs in India.

Concord Biotech Limited (CBL) is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients (APIs) sold worldwide.

<span class="mw-page-title-main">Laurus Labs</span> Indian pharmaceutical company

Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients (APIs), generic formulations, custom synthesis (CDMO), biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.

The Pharmaceutical industry in Gujarat ranks number one in India with a 33% share in drug manufacturing and a 28% share in drug exports. The state has 130 USFDA certified drug manufacturing facilities. Ahmedabad and Vadodara are considered as pharmaceutical hubs as there are many big and small pharma companies established in these cities.

References

  1. "Elder : Corporate - Introduction". Elderindia.com. Archived from the original on 29 December 2010. Retrieved 8 January 2011.
  2. "Elder Contact". Elderindia.com. Archived from the original on 16 December 2010. Retrieved 8 January 2011.
  3. 1 2 3 4 5 "BSE Plus". moneycontrol.com. Retrieved 21 December 2020.
  4. "Elder Pharma hiring 1,000 sales staff to tap India's rural market, pharma jobs in India Elder Pharma employment | DWS Pill Scribe". Dancewithshadows.com. 19 April 2010. Archived from the original on 26 April 2010. Retrieved 8 January 2011.
  5. "Elder Pharma to buy UK's NeutraHealth for $19.1 mn - Corporate News". Mint. 16 September 2010. Retrieved 8 January 2011.
  6. "Elder Pharma backs out of Ghana venture - Money". Daily News and Analysis. 15 January 2010. Retrieved 8 January 2011.
  7. "Elder Pharma gets Japanese approval for API facility". Business Standard India. Business-standard.com. Press Trust of India. 3 January 2011. Retrieved 8 January 2011.
  8. "How Elder Pharma was born". Rediff.com. 31 July 2004. Retrieved 8 January 2011.
  9. "Elder: Corporate History /Corporate Background". Elderindia.com. Archived from the original on 16 December 2010. Retrieved 8 January 2011.
  10. "NeutraHealth to be bought by India's Elder Pharma". Reuters. 16 September 2010. Retrieved 31 August 2023.
  11. "Torrent Pharma to buy Elder's India business for Rs 2,000 cr". Business Standard. Retrieved 31 August 2023.
  12. Rebello, Joel; Balakrishnan, Reghu (11 September 2015). "Elder Pharma to sell assets to clear debt". mint. Retrieved 31 August 2023.
  13. "Elder Pharmaceuticals drops after NSE announces trading suspension". Business Standard. Retrieved 31 August 2023.
  14. "The Visionary Entrepreneur of Elder Pharma late Jagdish Saxena was a man of emotions & a compassionate leader. Remembering the leader! – Indian Affairs". 6 May 2015.
  15. Balakrishnan, Reghu (10 October 2013). "Elder Pharma CMD Saxena passes away". Business Standard India via Business Standard.
  16. "Elder Pharma MD passes away, shadow over company intensifies". BusinessLine. 23 October 2017. Retrieved 31 August 2023.